Ethambutol-induced optic neuropathy: A nationwide population-based study from Taiwan

British Journal of Ophthalmology

Volumn 96, Issue 11, 2012, Pages 1368-1371

  Chen, Hsin Yi ^a,b   Lai, Shi Wei ^b,c   Muo, Chih Hsin ^a   Chen, Pei Chun ^a,d   Wang, I Jong ^a,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL;

ADULT; AGE; AGED; ALCOHOLISM; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; ETHAMBUTOL INDUCED OPTIC NEUROPATHY; FEMALE; GALLSTONE; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBESITY; OPTIC NERVE DISEASE; PALINDROMIC RHEUMATISM; POLYARTHRITIS; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; REITER SYNDROME; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; RISK FACTOR; RISK REDUCTION; SEX; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; TREATMENT DURATION;

ADULT; AGED; ANTITUBERCULAR AGENTS; ETHAMBUTOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TUBERCULOSIS; YOUNG ADULT;

EID: 84868130410     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-301870     Document Type: Article

References (19)

1. Sadun AA, Wang MY. Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year. J Neuroophthalmol 2008;28:265-8.
2. Choi SY, Hwang JM. Optic neuropathy associated with ethambutol in Koreans. Korean J Ophthalmol 1997;11:106-10.
3. Talbert Estlin KA, Sadun AA. Risk factors for ethambutol optic toxicity. Int Ophthalmol 2010;30:63-72.
4. Melamud A, Kosmorsky GS, Lee MS. Ocular ethambutol toxicity. Mayo Clin Proc 2003;78:1409-11.
5. Lee EJ, Kim SJ, Choung HK, et al. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol 2008;28:269-77.
6. Lim SA. Ethambutol-associated optic neuropathy. Ann Acad Med Singapore 2006;35:274-8.
7. Leibold JE. The ocular toxicity of ethambutol and its relation to dose. Ann N Y Acad Sci 1966;135:904-9.
8. Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther 1997;13:473-7.
9. Kumar A, Sandramouli S, Verma L, et al. Ocular ethambutol toxicity: is it reversible?. J Clin Neuroophthalmol 1993;13:15-7.
10. Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther 1995;11:411-19.
11. Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J 2006;12:56-60.
12. Zoumalan CI, Sadun AA. Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy. Br J Ophthalmol 2007;91:839-40.
13. Fraunfelder FW, Sadun AA, Wood T. Update on ethambutol optic neuropathy. Expert Opin Drug Saf 2006;5:615-18.
14. Sadun AA, Win PH, Ross-Cisneros FN, et al. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc 2000;98:223-32; discussion 32-5.
15. Menon V, Jain D, Saxena R, et al. Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol 2009;93:1251-4.
16. National Health Insurance Research Database. http://w3.nhri.org.tw/nhird/ /en/index.htm. Taiwan, 2011.
17. World Health Organization. Treatment of tuberculosis: guidelines 4th ed. Geneva, Switzerland: WHO, 2010.
18. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-85.
19. Ho JD, Hu CC, Lin HC. Open-angle glaucoma and the risk of stroke development: a 5-year population-based follow-up study. Stroke 2009;40:2685-90.